Mice study hints at nasal vaccine for universal respiratory protection
TL;DR
Stanford Medicine researchers report an intranasal vaccine that activates innate and adaptive immunity to provide months-long protection in mice against a broad spectrum of respiratory threats—SARS-CoV-2 and other coronaviruses, Staphylococcus aureus, Acinetobacter baumannii, and house dust mite allergen—suggesting a path toward a universal respiratory vaccine, with human safety trials planned next.
Topics:top-newsscience#innate-immunity#intranasal-vaccine#mouse-model#respiratory-infections#science#universal-vaccine
- One vaccine may provide broad protection against many respiratory infections and allergens Stanford Medicine
- Single vaccine could protect against all coughs, colds and flus, researchers say BBC
- Universal vaccine for cold, flu, COVID and allergies moves a step closer, scientists say Sky News
- AUDIO: How a universal vaccine could treat most respiratory diseases Australian Broadcasting Corporation
- New 4-in-1 ‘breakthrough’ jab could combat cold, flu, Covid AND allergies The Sun
Want the full story? Read the original reporting
Read on Stanford Medicine